In:
Pediatric Allergy and Immunology, Wiley, Vol. 32, No. 4 ( 2021-05), p. 679-689
Abstract:
Randomized controlled trials (RCTs) suggest a protective effect of high‐dose vitamin D supplementation in pregnancy on offspring risk of persistent wheeze, but only in some individuals, which might be explained by variations in vitamin D pathway genes. This study aimed to investigate the effect of vitamin D supplementation by maternal and offspring vitamin D receptor (VDR) genotype and GC genotype, encoding vitamin D binding protein (VDBP), in two RCTs. Methods In the Copenhagen Prospective Studies on Asthma in Childhood (COPSAC 2010 ) RCT, we analyzed the effect of high‐dose vitamin D during pregnancy on the risk of persistent wheeze age 0‐3 years by variants in single nucleotide polymorphisms (SNPs) in VDR (rs1544410, rs2228570, rs7975128, rs7975232) and GC (rs4588, rs7041). Replication was sought in the Vitamin D Antenatal Asthma Reduction Trial (VDAART). Results In COPSAC 2010 , VDR SNP rs1544410 influenced the effect of high‐dose vitamin D: maternal P interaction = .049 and child P interaction = .001, with the largest effect in offspring from mothers with TT genotype: hazard ratio (95% CI), 0.26 (0.10‐0.68), P = .006, and no effect among CT or CC genotypes: 0.85 (0.48‐1.51), P = .58 and 0.94 (0.47‐1.89), P = .87, respectively. However, these findings were not replicated in VDAART. There was no significant effect modification from maternal or offspring GC genotype in either COPSAC 2010 or VDAART: all P interaction ≥ .17. Conclusions We found that the effect of high‐dose vitamin D supplementation during pregnancy on offspring risk of persistent wheeze was significantly influenced by VDR genotype in the COPSAC 2010 RCT, but not VDAART, which may be due to population differences.
Type of Medium:
Online Resource
ISSN:
0905-6157
,
1399-3038
Language:
English
Publisher:
Wiley
Publication Date:
2021
detail.hit.zdb_id:
2008584-9
Permalink